Related Experiment Video
Updated: Nov 19, 2025

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
Vulvar Cancer with Cutaneous and Breast Metastases
Nawaraj Adhikari1, Adarsh Vennepureddy2, Sara Parylo2
1Department of Medicine, Staten Island University Hospital, 475 Seaview Avenue, Staten Island, NY 10305, USA.
Delayed diagnosis of vulvar cancer, a rare gynecologic malignancy, can lead to distant metastases. This case highlights concurrent skin and breast metastases from squamous cell carcinoma of the vulva.
Area of Science:
- Gynecologic Oncology
- Medical Case Reports
Background:
- Vulvar cancer represents approximately 5% of all female genital cancers.
- Early symptoms can be benign, potentially delaying diagnosis and treatment.
- Distant metastases are uncommon but have been documented in skin and breast tissues.
Observation:
- A 76-year-old female patient was diagnosed with squamous cell carcinoma of the vulva.
- A potential delay in diagnosis was noted.
- The patient presented with concurrent cutaneous and breast metastases four months post-diagnosis.
Findings:
- Squamous cell carcinoma of the vulva can metastasize distantly to the skin and breast.
- Delayed diagnosis may be associated with the development of advanced metastatic disease.
- Concurrent metastases to both skin and breast from vulvar cancer are rare but documented.
Implications:
- Highlights the importance of early detection and prompt diagnosis of vulvar cancer.
- Underscores the potential for aggressive behavior and distant spread of vulvar malignancies.
- Emphasizes the need for vigilance in monitoring for metastatic disease in patients with vulvar cancer.
More Related Videos
05:02Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
Published on: February 4, 2021
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...